Genmab A/S
CSE:GMAB

Watchlist Manager
Genmab A/S Logo
Genmab A/S
CSE:GMAB
Watchlist
Price: 1 414 DKK 3.44% Market Closed
Market Cap: 93.6B DKK

Intrinsic Value

The intrinsic value of one GMAB stock under the Base Case scenario is 2 563.98 DKK. Compared to the current market price of 1 414 DKK, Genmab A/S is Undervalued by 45%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

GMAB Intrinsic Value
2 563.98 DKK
Undervaluation 45%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Genmab A/S

GMAB
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for GMAB cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Genmab A/S
CSE:GMAB
DK
Biotechnology
Market Cap
89.8B DKK
IPO
Oct 1, 2000
DK
Biotechnology
Market Cap
89.8B DKK
IPO
Oct 1, 2000
Price
krfalse
EPS
krfalse
Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about GMAB?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Genmab A/S
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Genmab A/S

Current Assets 27.9B
Cash & Short-Term Investments 21.1B
Receivables 6.7B
Other Current Assets 62m
Non-Current Assets 18B
Long-Term Investments 228m
PP&E 1.9B
Intangibles 14.9B
Other Non-Current Assets 960m
Efficiency

Free Cash Flow Analysis
Genmab A/S

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Genmab A/S

Revenue
21.5B DKK
Cost of Revenue
-985m DKK
Gross Profit
20.5B DKK
Operating Expenses
-13.5B DKK
Operating Income
7.1B DKK
Other Expenses
765m DKK
Net Income
7.8B DKK
Fundamental Scores

GMAB Profitability Score
Profitability Due Diligence

Genmab A/S's profitability score is 79/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROIC
Positive Free Cash Flow
Positive Gross Profit
Exceptional 3-Years Revenue Growth
79/100
Profitability
Score

Genmab A/S's profitability score is 79/100. The higher the profitability score, the more profitable the company is.

GMAB Solvency Score
Solvency Due Diligence

Genmab A/S's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
99/100
Solvency
Score

Genmab A/S's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

GMAB Price Targets Summary
Genmab A/S

Wall Street analysts forecast GMAB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GMAB is 2 278.38 DKK with a low forecast of 1 445.31 DKK and a high forecast of 3 118.5 DKK.

Lowest
Price Target
1 445.31 DKK
2% Upside
Average
Price Target
2 278.38 DKK
61% Upside
Highest
Price Target
3 118.5 DKK
121% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Genmab A/S
does not pay dividends
Shareholder Yield

Current shareholder yield for GMAB is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

GMAB News

What is the Intrinsic Value of one GMAB stock?

The intrinsic value of one GMAB stock under the Base Case scenario is 2 563.98 DKK.

Is GMAB stock undervalued or overvalued?

Compared to the current market price of 1 414 DKK, Genmab A/S is Undervalued by 45%.

Back to Top